Cargando…
Cannabis Use and Fungal Infections in a Commercially Insured Population, United States, 2016
Case reports have identified invasive fungal diseases in persons who use cannabis, and fungal contamination of cannabis has been described. In a large health insurance claims database, persons who used cannabis were 3.5 (95% CI 2.6–4.8) times more likely than persons who did not use cannabis to have...
Autores principales: | Benedict, Kaitlin, Thompson, George R., Jackson, Brendan R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7258471/ https://www.ncbi.nlm.nih.gov/pubmed/32441624 http://dx.doi.org/10.3201/eid2606.191570 |
Ejemplares similares
-
Sporotrichosis Cases in Commercial Insurance Data, United States, 2012–2018
por: Benedict, Kaitlin, et al.
Publicado: (2020) -
Coccidioidomycosis Skin Testing in a Commercially Insured Population, United States, 2014–2017
por: Benedict, Kaitlin, et al.
Publicado: (2020) -
Presumed ocular histoplasmosis syndrome in a commercially insured population, United States
por: Benedict, Kaitlin, et al.
Publicado: (2020) -
Increased Hospitalizations Involving Fungal Infections during COVID-19 Pandemic, United States, January 2020–December 2021
por: Gold, Jeremy A.W., et al.
Publicado: (2023) -
Opportunities to improve guideline adherence for the diagnosis and treatment of onychomycosis: Analysis of commercial insurance claims data, United States
por: Gold, Jeremy A. W., et al.
Publicado: (2023)